We have developed a new protein-protein interaction (PPI) small molecule inhibitor drug discovery platform.
APG has signed a research cooperation agreement with the Helmholtz Institute in Munich.
We have currently two drug discovery programs:
Huntington's disease and a transcription factor inhibitor for cancer treatment.
COPYRIGHT © 2014 | ALL RIGHTS RESERVED
PRIVACY STATEMENT | TERMS & CONDITIONS